[Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D004467:Economics; D005193:Family Planning Services; D045167:Progesterone Congeners; D012106:Research; D013672:Technology
D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D003276:Contraceptives, Oral; D003277:Contraceptives, Oral, Combined; D045167:Progesterone Congeners
Clinical Research; Contraception; Contraceptive Agents; Contraceptive Agents, Female; Contraceptive Agents, Progestin; Contraceptive Methods; Economic Factors; Family Planning; Oral Contraceptives; Oral Contraceptives, Combined; Oral Contraceptives, Low-dose; Oral Contraceptives, Phasic; Progestins, Low-dose; Research And Development; Research Methodology; Technology
Trente ans apres la contraception orale, analyse clinique et biologique d'une nouvelle association estroprogestative triphasique au gestodene.